To demonstrate the specificity of this antibody, the rhabdomyosarcoma cell line Rh30, which expresses PANX1 37, was used to generate knockout (KO) controls utilizing the CRISPR-Cas9 system with two independent guide pairs (KO-1 and KO-2). Here, PANX1 is linked to rhabdomyosarcoma.